Shinpoong Pharmaceutical Co (XKRX:019170) Ending Cash Position : ₩47,300 Mil (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Shinpoong Pharmaceutical Co Ending Cash Position?

Shinpoong Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩47,300 Mil.

Shinpoong Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2023 (₩58,918 Mil) to Dec. 2023 (₩43,800 Mil) but then increased from Dec. 2023 (₩43,800 Mil) to Mar. 2024 (₩47,300 Mil).

Shinpoong Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2021 (₩27,637 Mil) to Dec. 2022 (₩41,691 Mil) and increased from Dec. 2022 (₩41,691 Mil) to Dec. 2023 (₩43,800 Mil).

Shinpoong Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Shinpoong Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shinpoong Pharmaceutical Co Ending Cash Position Chart

Shinpoong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

23,374.21

55,802.61

27,636.74

41,690.73

43,800.11

Shinpoong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															49,181.82	48,121.76	58,917.84	43,800.11	47,300.48

Shinpoong Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Shinpoong Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	41690.733	+	2109.38
	=	43,800

Shinpoong Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	43800.112	+	3500.367
	=	47,300

Shinpoong Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Shinpoong Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shinpoong Pharmaceutical Co (XKRX:019170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019170) » Definitions » Ending Cash Position

Traded in Other Exchanges

019175:Korea

Address

161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246

Website

https://shinpoong.co.kr

Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.

Shinpoong Pharmaceutical Co (XKRX:019170) Headlines

No Headlines